Russian Uran-9 combat UGV to complete trials in 2020

The state trials of Russia’s improved Uran-9 tracked unmanned combat ground vehicle (UCGV) will be completed this year, Ground Forces Commander-in-Chief Army Gen. Oleg Salyukov said in an interview with the Krasnaya Zverda newspaper published on December 9. According to the official, various robotic platforms are currently in development in Russia.
Follow Army Recognition on Google News at this link

Army Recognition Global Defense and Security news
Uran-9 combat UGV (Picture source: Army Recognition)

"Simultaneously, the work to create heavy and medium-class unmanned ground combat vehicles (Shturm and Soratnik) are under way with the aim of creating advanced units of the ground forces", Ground Forces Commander-in-Chief Army Gen. Oleg Salyukov said.

The Uran-9 has been developed and is produced by JSC 766 UPTK (currently by Kalashnikov Concern), and promoted and offered by Rosoboronexport for the international market. The 12-tonne UCGV is designed for reconnaissance, fire support and anti-tank missions. It is armed with a 2A72 mod. ABM M30-M3 30mm autocannon from Impul's 2 (Sevastopol'), a 7.62-mm machine gun, a Shmel-M rocket-assisted flamethrower, Ataka anti-tank guided missile launchers (or other type), also Igla or Strela SAMs, FCS, cam IR sensors, and laser rangefinder.

The Uran-9 was first deployed during the Syrian Civil War, though according to a performance report of the 3rd Central Research Institute of the Ministry of Defence of the Russian Federation, the UCGV functioned poorly, and was unable to perform many of the missions assigned to it. On the other hand, an industry source claimed that “the vehicle has been tested in Syria and demonstrated high performance in an operational environment”, also noting that industry has consequently improved the system to increase the Uran-9's range, response time, and data bandwidth. Uran-9 was also used in the large-scale Vostok 2018 drills. The Uran-9 robotic armed vehicle finally entered military service in January 2019 while still undergoing various trials.